UNITUXIN (dinutuximab) injection is used for the treatment of patients with neuroblastoma (a type of brain tumor) in children

Unituxin is a GD2-binding monoclonal antibody indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy

UNITUXIN (dinutuximab) injection suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of UNITUXIN (dinutuximab) injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the UNITUXIN (dinutuximab) injection medicine cost price in India.

The order for UNITUXIN (dinutuximab) injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Dinutuximab (Ch14.18, tradename Unituxin) and Dinutuximab beta (tradename Isquette) is a monoclonal antibody used as a second-line treatment for children with high-risk neuroblastoma. Each antibody is made of both mouse and human components and targets glycolipid GD2, expressed on neuroblastoma cells and on normal cells of neuroectodermal origin, including the central nervous system and peripheral nerves.

UNITUXIN™ (dinutuximab) injection, for intravenous use Initial U.S. Approval: 2015

Generic Name: dinutuximab

Injection: 17.5 mg/5 mL (3.5 mg/mL) in a single-use vial.

UNITUXIN (dinutuximab) injection

UNITUXIN (dinutuximab) injection is available.

Get In Touch

UNITUXIN (dinutuximab) injection suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand UNITUXIN (dinutuximab) injection on prescription and Import License in Patient's Name only.

For overseas patients, UNITUXIN (dinutuximab) injection can be made available in Send your enquiry to find UNITUXIN (dinutuximab) injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for UNITUXIN (dinutuximab) injection.

For UNITUXIN (dinutuximab) injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

FDA Approves Unituxin™ (dinutuximab) for the Treatment of Pediatric High-Risk Neuroblastoma For More Details

FDA Grants N-803 Combo Breakthrough Therapy Status for Non-Muscle Invasive Bladder Cancer For More Details

Channel Partner In India

Delhi Office

60/4, T&T House. Yusuf Sarai,
New Delhi:110016

Bangalore Office

#308, Raheja Chambers, 12,
Museum Road, Bangalore 560 001

Kolkata Office

1/A R.G Kar Road, Shayambazar,
Kolkata 700004

Lucknow Office

203-A, 2nd Floor, Tower -11, Felix
Square, IBB-2, Sushant Golf city, Lucknow 226030